Quinidine polygalacturonate

聚半乳糖醛酸奎尼丁

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameQuinidine polygalacturonate
Drug Alias NameNaticardinaCardioquinGalactoquin
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionSodium channel alpha subunit blockersCytochrome P450 inhibitorsAlpha adrenergic receptor antagonists +[4] 
TargetsSodium channel alpha subunitCytochrome P450Alpha adrenergic receptor +[4] 
Therapy Area/IndicationsAtrial FlutterArrhythmias, CardiacVentricular Arrhythmia
Global Approved IndicationsAtrial FlutterArrhythmias, CardiacVentricular Arrhythmia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1961/01/01
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMundipharma International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaceutical Research Associates, IncPurdue Pharma
Active IndicationsN/A
Inactive IndicationsAtrial FlutterArrhythmias, CardiacVentricular Arrhythmia

Other Information

ATC CodeC01BA01
Related LinksWikipediaDrugBankKEGG